Eric Vangrevelinghe

Eric Vangrevelinghe

Novartis Institutes for BioMedical Research - Bhubaneswar / United States
Engineering & Technology / Computer Science
AD Scientific Index ID: 4395200
-
person_outline Eric Vangrevelinghe's MOST POPULAR ARTICLES
1-) Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition Journal of experimental medicine 209 (2), 259-273, 2012
2-) Modulation of activation-loop phosphorylation by JAK inhibitors is binding mode dependent Cancer discovery 2 (6), 512-523, 2012
3-) Potent and selective inhibition of polycythemia by the quinoxaline JAK2 inhibitor NVP-BSK805 Molecular cancer therapeutics 9 (7), 1945-1955, 2010
4-) Modulation of activation-loop phosphorylation by JAK inhibitors is binding mode dependentR Andraos, Z Qian, D Bonenfant, J Rubert, E Vangrevelinghe, C Scheufler, ...Cancer discovery 2 (6), 512-523, 20121532012
5-) Potent and selective inhibition of polycythemia by the quinoxaline JAK2 inhibitor NVP-BSK805F Baffert, CH Régnier, A De Pover, C Pissot-Soldermann, GA Tavares, ...Molecular cancer therapeutics 9 (7), 1945-1955, 20101472010